862574-74-1 Usage
Uses
Used in Pharmaceutical Industry:
(5-[1-hydroxy-2-(2-methoxy-phenyl)-ethyl]-thiazol-2-yl)-carbamic acid tert-butyl ester is used as a pharmaceutical intermediate for its potential role in the development of new drugs. Its unique structure and chemical properties make it a valuable building block in the synthesis of various medicinal compounds.
Used in Organic Synthesis:
In the field of organic synthesis, (5-[1-hydroxy-2-(2-methoxy-phenyl)-ethyl]-thiazol-2-yl)-carbamic acid tert-butyl ester serves as a key building block. Its structural features and reactivity contribute to the creation of a wide range of complex organic molecules, which can be utilized in various applications, including the development of novel pharmaceuticals, agrochemicals, and other specialty chemicals.
Used in Drug Development:
(5-[1-hydroxy-2-(2-methoxy-phenyl)-ethyl]-thiazol-2-yl)-carbamic acid tert-butyl ester is used as a compound of interest in drug development. Its unique chemical structure and properties may lead to the discovery of new therapeutic agents, particularly in the areas of pharmaceuticals and related industries. Further research and development could potentially unlock its full potential in creating innovative treatments for various medical conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 862574-74-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,6,2,5,7 and 4 respectively; the second part has 2 digits, 7 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 862574-74:
(8*8)+(7*6)+(6*2)+(5*5)+(4*7)+(3*4)+(2*7)+(1*4)=201
201 % 10 = 1
So 862574-74-1 is a valid CAS Registry Number.
862574-74-1Relevant academic research and scientific papers
MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS
-
Page/Page column 140, (2010/02/13)
The present invention relates to modulators of ATP-Binding Cassette ("ABC") transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator ("CFTR"), compositions thereof, and methods therewith. The present invention also relates to methods of treating ABC transporter mediated diseases using such modulators (I) or a pharmaceutically acceptable salt thereof, wherein: Ht is a 5-membered heteroaromatic ring containing 1-4 heteroatoms selected from O, S, N or NH, wherein said ring is optionally fused to a 6-membered monocyclic or 10-membered bicyclic carbocyclic or heterocyclic, aromatic or non-aromatic ring, wherein Ht is optionally substituted with w occurrences of -WRw, wherein w is 0-5; ring A is 3-7 membered monocyclic ring having 0-3 heteroatoms selected from O, S, N, or NH, wherein ring A is optionally substituted with q occurrences of QRQ; ring B is optionally fused to 5-6 membered carbocyclic or heterocyclic, aromatic or non-aromatic ring .
